Log in

NASDAQ:CALTLegend Biotech Stock Price, Forecast & News

$23.60
+0.41 (+1.77 %)
(As of 07/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$22.96
Now: $23.61
$24.71
50-Day Range N/A
52-Week Range
$19.00
Now: $23.61
$24.97
Volume67,547 shs
Average Volume40,514 shs
Market Capitalization$565.79 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing pharmaceutical products for patients with unmet medical needs. The company's lead product candidate is Nefecon, a unique formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy. Calliditas Therapeutics AB (publ) also intends to take Nefecon through a global Phase 3 study to commercialization. The company was founded in 2004 and is headquartered in Stockholm, Sweden.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:CALT
CUSIPN/A
CIKN/A
Phone46-8411-3005

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees17
Market Cap$565.79 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CALT News and Ratings via Email

Sign-up to receive the latest news and ratings for CALT and its competitors with MarketBeat's FREE daily newsletter.

Legend Biotech (NASDAQ:CALT) Frequently Asked Questions

Has Legend Biotech been receiving favorable news coverage?

News coverage about CALT stock has trended very negative this week, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Legend Biotech earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Legend Biotech.

Who are some of Legend Biotech's key competitors?

Who are Legend Biotech's key executives?

Legend Biotech's management team includes the following people:
  • Ms. Renee Aguiar-Lucander, Chief Exec. Officer (Age 58)
  • Mr. Mikael Bender, Co-Founder
  • Mr. Fredrik Johansson, Chief Financial Officer (Age 43)
  • Ms. Katayoun Welin-Berger, VP Operations (Age 52)
  • Dr. Johan Haggblad, Chief Scientific Officer (Age 62)

When did Legend Biotech IPO?

(CALT) raised $179 million in an initial public offering (IPO) on Friday, June 5th 2020. The company issued 9,200,000 shares at a price of $19.50 per share. Citigroup, Jefferies and Stifel served as the underwriters for the IPO and Carnegie was co-manager.

What is Legend Biotech's stock symbol?

Legend Biotech trades on the NASDAQ under the ticker symbol "CALT."

When does Legend Biotech's quiet period expire?

Legend Biotech's quiet period expires on Wednesday, July 15th. Legend Biotech had issued 4,153,385 shares in its initial public offering on June 5th. The total size of the offering was $80,991,008 based on an initial share price of $19.50. During Legend Biotech's quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Legend Biotech?

Shares of CALT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Legend Biotech's stock price today?

One share of CALT stock can currently be purchased for approximately $23.61.

How big of a company is Legend Biotech?

Legend Biotech has a market capitalization of $565.79 million. Legend Biotech employs 17 workers across the globe.

What is Legend Biotech's official website?

The official website for Legend Biotech is www.calliditas.se.

How can I contact Legend Biotech?

Legend Biotech's mailing address is KUNGSBRON 1 C8, STOCKHOLM V7, 11122. The company can be reached via phone at 46-8411-3005 or via email at [email protected]

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.